StonvexLoading…
StonvexStonvexStonvexCore line items from BG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $16.94B | $15.55B | $17.83B | $21.07B |
Operating Income | $1.13B | $1.52B | $3.05B | $2.07B |
Net Income | $816.00M | $1.14B | $2.24B | $1.61B |
EPS (Diluted) | $4.91 | $7.99 | $14.87 | $10.51 |
Total Assets | $44.53B | $24.90B | $25.37B | $24.58B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.14B | $3.31B | $2.60B | $1.10B |
Free Cash Flow OCF − CapEx | $-879.00M | $524.00M | $2.19B | $-6.10B |
Shares Outstanding | 166.47M | 142.22M | 150.79M | 153.13M |